Articles
INnovative Steroid Treatment to reduce Asthma development in children after first-time Rhinovirus-induced wheezing (INSTAR)
A study is investigating if a short course of oral dexamethasone can prevent recurrent wheezing and asthma in steroid-naïve infants (3-23 months) experiencing their first rhinovirus-induced wheezing episode.
Asthma is a leading cause of morbidity and healthcare use among children. Risk factors of childhood asthma include atopic predisposition and severe wheezing episodes caused by rhinovirus infection in early life.
Click here to access the article.